Catalyst Reaction · NASDAQ: AYTU · Drug Manufacturers - Specialty & Generic
Aytu BioPharma (AYTU): shareholder Alert: Ademi LLP, a 46.2% session and what followed
Aytu BioPharma (AYTU) announced shareholder Alert: Ademi LLP at 8:55 AM ET on Tuesday, November 17, and the stock went from Monday’s $1.82 close to as high as $2.67 before the open. It finished the session +46.2% at $2.66 on 44.7 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.
By IndicatorStack · · All times ET
The catalyst
What the company released or filed, to the minute it crossed. It’s in the timeline as a shaded row, linked to the source.
How it traded
The price around it, session by session: the gap, the range, the close, with the chart LiveChart draws from those bars.
How the stack read it
LiveChart’s read at each turn: the 5-minute trend (the stack bias), the higher timeframes (Compass), the flow (Undertow) and traps (Tripwire).
How the stack read it, checkpoint by checkpoint
The stack bias is LiveChart’s read of the 5-minute trend at that moment: a green dot is bullish, red bearish, grey no clear direction. Under it, what Compass read on the higher timeframes the trend is measured against.
- BeforeBullishMon close · $1.8015m and 1h split
- Into the openBullishTue 9:30 AM · $2.6715m and 1h up
- 30 minutes inBullishTue 10:00 AM · $2.6615m and 1h up
- At the closeNeutralTue 4:00 PM · $2.6515m and 1h up
- Wednesday’s closeNeutralWed 4:00 PM · $2.6615m and 1h up
The timeline
Everything that happened, in order, on one ET clock: the company’s releases and SEC filings next to the price and the stack’s own turns.
- ReleaseSECShaded rows are the catalyst: the company’s own releases and filings
- PriceThe session’s open, high, low and close
- StackLiveChart’s 5-minute bias changed
- TriggerA hypothetical entry at the default settings
- TripwireA break of a level that failed to hold
Monday, November 16
- SECCurrent report (Form 8-K) filedAccepted by the SEC at 4:03:17 PM ET
- ReleaseRosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansionPress release, GlobeNewsWire
- SECCurrent report (Form 8-K) filedAccepted by the SEC at 4:17:18 PM ET
- SECQuarterly report (Form 10-Q) filedAccepted by the SEC at 4:23:52 PM ET
Tuesday, November 17
- ReleaseShareholder Alert: Ademi LLPPress release, GlobeNewsWire
- PricePremarket high $2.67+46.7% from the prior close
- PriceOpened at $2.66+46.2% from Monday’s $1.82 close
- PriceSession low $2.65
- ReleaseBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying investors of thePress release, GlobeNewsWire
- Stack5-minute stack bias turned bearishat $2.65
- Stack5-minute stack bias went neutralat $2.66, its inputs no longer agreeing
- PriceClosed at $2.66, +46.2% on the day4.4M shares, 44.7× its 20-day average
Wednesday, November 18
- PriceSession low $2.65
- PriceOpened at $2.65−0.4% from Tuesday’s $2.66 close
- Stack5-minute stack bias turned bullishat $2.66
- Stack5-minute stack bias went neutralat $2.65, its inputs no longer agreeing
- PriceClosed at $2.66, +0.0% on the day376K shares, 1.2× its 20-day average
Monday, November 16
Before the catalyst
Aytu BioPharma closed Monday at $1.82. The 5-minute stack bias was bullish (weakening), since 11:00 AM: momentum up. Compass read “15m and 1h split” (15m ↗ 1h ↓ 2h ↓ 4h ↓ D ↘). Undertow: buying drying up, sellers absorbing the pushes. Tripwire: Longs: Caution, against the daily and weekly cycle. Its Next row read “Lost VWAP 1.80, buyers need a reclaim”.
Over the year before, it had traded between $1.75 and $3.07. The daily chart below shows where it was trading, and the bar the catalyst printed.
Bullishweakening · 5m stack bias · $1.80
- Compass
- 15m and 1h split
- Undertow
- Buying drying up
- Tripwire
- Longs: Caution
- Next
- Lost VWAP 1.80, buyers need a reclaim
Tuesday, November 17
The release and a 46.2% session
The release crossed at 8:55 AM ET. It opened at $2.66, +46.2%, and the regular session ranged from $2.65 to $2.67 before closing at $2.66. It did this on a day SPY fell 1.0% and XLV, the drug manufacturers - specialty & generic ETF, fell 1.4%.
Into the open the stack read it as bullish (firm) with 2 of 2 higher timeframes up, and Undertow read “thin tape”. Thirty minutes in, the picture had changed: price held above VWAP at $2.65 and the Next row read “Pullback, support to hold at 2.66 (slow EMA)”. By the close the 5-minute bias was neutral, while Compass still read “15m and 1h up”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.
Bullishfirm · 5m stack bias · $2.67
- Compass
- 15m and 1h up
- Undertow
- Thin tape
- Tripwire
- Longs: Clean
- Next
- Buying drying up near 2.67, giveback risk rising
Bullishweakening · 5m stack bias · $2.66
- Compass
- 15m and 1h up
- Undertow
- Volume surge
- Tripwire
- Longs: Clean
- Next
- Pullback, support to hold at 2.66 (slow EMA)
Neutral5m stack bias · $2.65
- Compass
- 15m and 1h up
- Undertow
- Volume surge
- Tripwire
- Shorts: Avoid
- Next
- Range 2.65 to 2.66, no edge in the middle
Wednesday, November 18
The session after
It opened at $2.65 (−0.4%) and traded from $2.65 to $2.66, closing at $2.66, +0.0% on 376K shares, still 1.2 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h up” (15m ↗ 1h ↑ 2h ↑ 4h ↑ D ↑). Undertow: sellers lead, no large size yet. Tripwire: Longs: Clean, nothing major in the way.
After hours it last traded at $2.66, with Undertow reading “hidden selling”.
Neutral5m stack bias · $2.66
- Compass
- 15m and 1h up
- Undertow
- Sellers lead
- Tripwire
- Longs: Clean
- Next
- Coiled 2.65 to 2.66, direction comes on the break
Neutral5m stack bias · $2.66
- Compass
- 15m and 1h up
- Undertow
- Hidden selling
- Tripwire
- Longs: Clean
- Next
- Coiled 2.65 to 2.66, direction comes on the break
Shares, float and insiders
The supply picture
What the company has outstanding, and what its insiders and its share history show, from its SEC filings.
- Shares outstanding
- 10.9Mas reported to the SEC
- Float
- 10M92% of shares outstanding
- Reverse splits on record
- 71-for-20 reverse split, January 6, 2023; 1-for-10 reverse split, December 9, 2020; 1-for-20 reverse split, August 13, 2018; 1-for-20 reverse split, August 29, 2017; 1-for-12 reverse split, October 28, 2016; 1-for-12 reverse split, July 1, 2016; 41-for-500 reverse split, June 10, 2015
- Last insider purchase
- November 18, 202010K shares at $0.9230 by DOCKERY CARL (director)
- Last insider sale
- December 30, 2020209 shares at $6.01
Releases and filings
Sources
The company’s own releases and its filings with the SEC, newest first, each with the time it crossed.
- ReleaseBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying investors of theTue Nov 17, 10:48 AM ET · GlobeNewsWire
- ReleaseShareholder Alert: Ademi LLPTue Nov 17, 8:55 AM ET · GlobeNewsWire
- SECQuarterly report (Form 10-Q)Mon Nov 16, 4:23 PM ET · SEC EDGAR
- SECCurrent report (Form 8-K)Mon Nov 16, 4:17 PM ET · SEC EDGAR
- ReleaseRosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansionMon Nov 16, 4:11 PM ET · GlobeNewsWire
- SECCurrent report (Form 8-K)Mon Nov 16, 4:03 PM ET · SEC EDGAR
In short
Questions
Why did AYTU stock go up on November 17?
AYTU finished the session +46.2% at $2.66 on 44.7 times its 20-day average volume. The timeline on this page lists every release and filing around the move, each timed to the minute. The reaction describes the sequence and infers no cause.
What did Aytu BioPharma announce on November 17, 2026?
Aytu BioPharma (AYTU) announced shareholder Alert: Ademi LLP at 8:55 AM ET on Tuesday, November 17.
How did AYTU stock trade on November 17?
AYTU opened at $2.66, +46.2% from the prior close of $1.82, traded between $2.65 and $2.67 in the regular session and closed at $2.66, +46.2%, on 4.4M shares.
How did LiveChart’s stack read AYTU at the close on November 17?
At the 4:00 PM ET close the 5-minute stack bias on AYTU was neutral, Compass read “15m and 1h up” and Undertow read “volume surge”. Each turn of the read is on this page’s timeline.
What does LiveChart’s stack read on AYTU now?
The read on this page is fixed at each moment it describes. LiveChart reads AYTU on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.
Every catalyst on AYTU
AYTU’s catalyst history
This is AYTU’s first Catalyst Reaction. Each time it moves on a release or a filing again, the reads line up here side by side, so how it reacts to its own news builds into a history.
| Session | The catalyst | The day | Next session | Stack bias at the close |
|---|---|---|---|---|
| Nov 17, 2026This reaction | Shareholder Alert: Ademi LLPCompany news · 8:55 AM ET | +46.2% | +0.0% | Neutral |
Also on Tuesday, November 17
More Catalyst Reactions from that session
- Nov 1710:00 AM ETMPU+65.6%Mega Matrix (MPU): Former Polygon Labs and Mega Matrix Exec Colin, a 65.6% session and what followedCompany news746.1× avg volume
- Nov 177:32 AM ETFRTT+77.7%Fort Technology (FRTT): record Year-to-Date revenues of $12 million, a 77.7% session and what followedCompany news38.2× avg volume
- Nov 177:00 AM ETSLS+156.4%SELLAS (SLS): Phase 3 data, a 156% session and a $13.00 offeringTrial data15.7× avg volume
- Nov 177:00 AM ETSMTK+66.0%SmartKem (SMTK): merger partner Ferrox advances Global, a 66.0% session and what followedCompany news103.3× avg volume
- Nov 176:00 AM ETGLSI+35.9%Greenwich LifeSciences (GLSI): Acceptance of abstracts at SABCS 2026, a 35.9% session and what followedCompany news8.6× avg volume
- Nov 174:48 PM ETCUE−79.9%Cue Biopharma (CUE): quarterly results, a 79.9% drop and what followedEarnings28.8× avg volume
Every Reaction From Nov 17More Company News ReactionsAYTU Catalyst HistoryAYTU on LiveChartTechnical Setups RadarAll Catalyst ReactionsIntraday Movers
Further reading: Gaps: continuation and exhaustionLow-float riskWhat VWAP tells youTrading around halts
General market information from the company’s releases, its SEC filings, the session’s prices and LiveChart’s reads. Prices are indicative. It describes what happened and when, infers no cause, takes no view on what comes next and is not a recommendation to buy or sell any security. Trigger trades are hypothetical. Read the Risk Disclosure.